{
  "docId": "019de076-c164-739c-925e-e97b24983f20",
  "docSlug": "45699c5d62cd10656fd74cee2718d284",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 33,
  "pageCount": 45,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "appendix",
  "function": "appendix",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-c164-739c-925e-e97b24983f20/33",
  "deckHref": "/decks/019de076-c164-739c-925e-e97b24983f20",
  "deckJsonHref": "/decks/019de076-c164-739c-925e-e97b24983f20.json",
  "deckAnchorHref": "/decks/019de076-c164-739c-925e-e97b24983f20#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.4,
        "x": 0.06,
        "y": 0.18
      },
      "kind": "list",
      "text": "NRDL = national reimbursement drug list\nNSCLC = non-small cell lung cancer\nNST = neoadjuvant systemic treatment\noGLP1 = oral glucagon-like receptor peptide 1\noPCSK9 = oral protein convertase subtilisin/kexin type 9\nORR = overall response rate\noRXFP1 = oral relaxin family peptide receptor 1\nPARPi = poly(ADP-ribose) polymerase-1\nPD1 = Programmed cell death protein 1\nPD-L1 = Programmed cell death ligand 1\nPIK3CA = phosphatidylinositol-4,5-biphosphate 3-kinase catalytic subunit\nPNH = paroxysmal nocturnal haemoglobinuria\nPS = product sales\nPTEN = phosphatase and TENsin homolog deleted on chromosome 10\nQ4W = every 4 weeks\nQoQ = quarter on quarter\nR&D = research and development\nR&I = respiratory and immunology\nRSV = respiratory syncytial\nSBRT = Stereotactic brain radiotherapy\nSG&A = sales, general and administrative\nSoC = standard of care\nStg I/II/III = Stage 1/2/3\nTIGIT = T-cell immunoreceptor with immunoglobulin and ITIM domains\nTKI = tyrosine kinase inhibitor\nTIM-3 = T-cell immunoglobulin and mucin domain-containing protein\nTNBC = triple negative breast cancer\nTTR = transthyretin\nu/r HTN = uncontrolled or treatment resistant hypertension\nV&I = vaccines and immune therapies",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab26ec22-3652-4ad1-b14a-2a36835c1d5a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.55,
        "x": 0.034,
        "y": 0.078
      },
      "kind": "title",
      "text": "Glossary – abbreviations (2 of 2)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f25821a6-7806-4686-9688-22363e78ab50",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}